SBIR Phase II:Polyvalent Bacteriophages as Livestock Feed Additives and Alternatives to Antibiotics for Pathogen Control and Improved Animal Performance
SBIR 第二阶段:多价噬菌体作为牲畜饲料添加剂和抗生素替代品,用于病原体控制和改善动物生产性能
基本信息
- 批准号:2025980
- 负责人:
- 金额:$ 99.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Cooperative Agreement
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-15 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The broader impact of this Small Business Innovation Research (SBIR) Phase II project will be to mitigate the spread of antibiotic resistant bacteria. In the United States, antibiotic resistance is estimated to cause over 2 million illnesses, 23,000 deaths, and cost $55 billion annually. Worldwide, it causes 700,000 deaths annually, and reduces global gross domestic product by approximately 1.5% through its impact on income, productivity, investment and healthcare costs. The animal sector accounts for up to 80% of antibiotic consumption in some countries. However, antibiotic feed additives are widely used in the cattle industry because they provide significant economic and animal welfare benefits by reducing the incidence and severity of liver abscesses. As the industry already operates on narrow profit margins, withdrawing antibiotic feed additives may be financially catastrophic for many producers, and could lead to supply chain disruption. This project provides a solution to the beef cattle industry through development of a cost-effective alternative to antibiotic feed additives.The proposed project aims to develop a bacteriophage-based feed additive to inhibit the growth of the primary etiologic agent of bovine liver abscesses, Fusobacterium necrophorum, and reduce or eliminate the need for antibiotic feed additives in feedlot cattle. The first project objective is to convert a library of temperate bacteriophages to obligately lytic mutants to enhance their suitability for long-term inhibition of Fusobacterium necrophorum in cattle rumen. The second objective is to optimize and scale up production of these bacteriophages and develop a product formulation that can be readily integrated into cattle rations. The final objective is to conduct feeding trials to optimize dosing requirements and obtain in vivo proof of efficacy.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
该小企业创新研究 (SBIR) 第二阶段项目的更广泛影响将是减轻抗生素耐药细菌的传播。在美国,抗生素耐药性估计会导致超过 200 万人患病、23,000 人死亡,每年造成 550 亿美元的损失。在全球范围内,它每年造成 70 万人死亡,并通过其对收入、生产力、投资和医疗保健成本的影响,使全球国内生产总值减少约 1.5%。在一些国家,畜牧业占抗生素消费量的 80%。然而,抗生素饲料添加剂广泛用于养牛业,因为它们通过降低肝脓肿的发生率和严重程度来提供显着的经济和动物福利效益。由于该行业的利润率已经很低,因此撤回抗生素饲料添加剂可能会给许多生产商带来财务灾难,并可能导致供应链中断。该项目通过开发一种具有成本效益的抗生素饲料添加剂替代品,为肉牛行业提供了一种解决方案。该项目旨在开发一种基于噬菌体的饲料添加剂,以抑制牛肝脓肿的主要病原体梭杆菌的生长necrophorum,并减少或消除饲养场牛对抗生素饲料添加剂的需求。第一个项目目标是将温带噬菌体文库转化为专性裂解突变体,以增强其对牛瘤胃中坏死梭杆菌长期抑制的适用性。第二个目标是优化和扩大这些噬菌体的生产,并开发一种可以轻松融入牛口粮的产品配方。最终目标是进行喂养试验,以优化剂量要求并获得体内功效证明。该奖项反映了 NSF 的法定使命,并通过使用基金会的智力优点和更广泛的影响审查标准进行评估,被认为值得支持。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Unexpected finding of Fusobacterium varium as the dominant Fusobacterium species in cattle rumen: potential implications for liver abscess etiology and interventions
意外发现变异梭杆菌作为牛瘤胃中的优势梭杆菌:对肝脓肿病因和干预措施的潜在影响
- DOI:10.1093/jas/skad130
- 发表时间:2023
- 期刊:
- 影响因子:3.3
- 作者:Schwarz, Cory;Mathieu, Jacques;Gomez, Jenny Laverde;Miller, Megan R.;Tikhonova, Marina;Nagaraja, Tiruvoor. G.;Alvarez, Pedro J. J.
- 通讯作者:Alvarez, Pedro J. J.
Renaissance for Phage-Based Bacterial Control
- DOI:10.1021/acs.est.1c06232
- 发表时间:2022-04-19
- 期刊:
- 影响因子:11.4
- 作者:Schwarz, Cory;Mathieu, Jacques;Alvarez, Pedro J. J.
- 通讯作者:Alvarez, Pedro J. J.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jacques Mathieu其他文献
Proliferation of Multi-drug resistant New Delhi Metallo-b-lactamase genes in municipal wastewater treatment plants in northern China
中国北方城市污水处理厂多重耐药新德里金属-b-内酰胺酶基因的增殖
- DOI:
- 发表时间:
2014 - 期刊:
- 影响因子:0
- 作者:
Yi Luo;Fengxia Yang;Jacques Mathieu;Daqing Mao;Qing Wang;Pedro J. J. Alvarez - 通讯作者:
Pedro J. J. Alvarez
Persistence of extracellular DNA in river sediment faciliates antibiotic reristance gene propergation
河流沉积物中细胞外DNA的持续存在促进抗生素耐药基因的传播
- DOI:
- 发表时间:
2014 - 期刊:
- 影响因子:0
- 作者:
Daqing Mao;Yi Luo;Jacques Mathieu;Qing Wang;Ling Feng;Quanhua Mu;Chunyan Feng;P. J. J. Alvarez - 通讯作者:
P. J. J. Alvarez
Jacques Mathieu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jacques Mathieu', 18)}}的其他基金
SBIR Phase I: Polyvalent Bacteriophages as Livestock Feed Additives and Alternatives to Antibiotics for Pathogen Control and Improved Animal Performance
SBIR 第一阶段:多价噬菌体作为牲畜饲料添加剂和抗生素替代品,用于病原体控制和改善动物生产性能
- 批准号:
1820015 - 财政年份:2018
- 资助金额:
$ 99.99万 - 项目类别:
Standard Grant
I-Corps: Polyvalent Bacteriophages
I-Corps:多价噬菌体
- 批准号:
1741477 - 财政年份:2017
- 资助金额:
$ 99.99万 - 项目类别:
Standard Grant
相似国自然基金
热带河口特有鱼类尖鳍鲤早期生活史不同阶段的栖息地利用变化及驱动机制
- 批准号:32360917
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
PPP项目跨阶段监管机制研究
- 批准号:72301115
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗生素对不同生长阶段蓝藻光合电子传递和生理代谢的影响及分子机制研究
- 批准号:52300219
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多活性纳米酶多靶点全阶段治疗特发性肺纤维化
- 批准号:32371438
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于现代监测的湘西惹迷洞MIS2阶段石笋碳同位素和微量元素记录重建研究
- 批准号:42371164
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
相似海外基金
SBIR Phase II: Innovative Two-Phase Cooling with Micro Closed Loop Pulsating Heat Pipes for High Power Density Electronics
SBIR 第二阶段:用于高功率密度电子产品的创新两相冷却微闭环脉动热管
- 批准号:
2321862 - 财政年份:2024
- 资助金额:
$ 99.99万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Innovative Glass Inspection for Advanced Semiconductor Packaging
SBIR 第二阶段:先进半导体封装的创新玻璃检测
- 批准号:
2335175 - 财政年份:2024
- 资助金额:
$ 99.99万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Intelligent Language Learning Environment
SBIR第二阶段:智能语言学习环境
- 批准号:
2335265 - 财政年份:2024
- 资助金额:
$ 99.99万 - 项目类别:
Cooperative Agreement
SBIR Phase II: FlashPCB Service Commercialization and AI Component Package Identification
SBIR第二阶段:FlashPCB服务商业化和AI组件封装识别
- 批准号:
2335464 - 财政年份:2024
- 资助金额:
$ 99.99万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Thermally-optimized power amplifiers for next-generation telecommunication and radar
SBIR 第二阶段:用于下一代电信和雷达的热优化功率放大器
- 批准号:
2335504 - 财政年份:2024
- 资助金额:
$ 99.99万 - 项目类别:
Cooperative Agreement